Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Tva Medical Inc. is currently managing 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. All 3 of these actions are concentrated within 1 distinct art unit, which indicates a very tight technical focus for the company's current patent applications. This concentration in 1 art unit allows the company to develop a prosecution strategy that aligns with the specific examination standards of that division.
The workload is distributed between 2 distinct examiners for the 3 pending office actions. This means that at least one examiner is handling multiple cases for the company. Having 2 distinct examiners for the 3 actions provides some diversification in the prosecution experience while still maintaining a small pool of USPTO contacts.
BOCK, ABIGAIL MARIE is the busiest examiner for the company, with 2 pending office actions currently under review. Since the busiest examiner handles 2 of the 3 pending office actions, her individual review process has a significant impact on the company's portfolio. This concentration requires the company to pay close attention to the specific preferences of BOCK, ABIGAIL MARIE to ensure the success of these active cases.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §102 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOCK, ABIGAIL MARIE | 2 | 91.0% | +7.3% |
| DELLA, JAYMI E | 1 | 68.8% | +29.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17997470 | SYSTEMS, METHODS, AND CATHETERS FOR ENDOVASCULAR TREATMENT OF A BLOOD VESSEL | BOCK, ABIGAIL MARIE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19104588 | A CATHETER FOR FORMING A FISTULA | BOCK, ABIGAIL MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16951730 | DEVICES AND METHODS FOR FISTULA FORMULATION | DELLA, JAYMI E | 31d overdue |
| Art Unit | Apps |
|---|---|
| 3794 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19104588 | A CATHETER FOR FORMING A FISTULA | BOCK, ABIGAIL MARIE | — | §102§103 | Non-Final OA | — | Pending | Feb 18, 2025 |
| 17997470 | SYSTEMS, METHODS, AND CATHETERS FOR ENDOVASCULAR TREATMENT OF A BLOOD VESSEL | BOCK, ABIGAIL MARIE | 3794 | §103 | Non-Final OA | — | Pending | Oct 28, 2022 |
| 16951730 | DEVICES AND METHODS FOR FISTULA FORMULATION | DELLA, JAYMI E | 3794 | §102 | Final Rejection | 31d overdue | Pending | Nov 18, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial